KRYSTAL FRANCO: Open Payments
NPI 1609494806 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 10 payments from 7 companies in 2025. Trend: 2023 $236 · 2024 $146 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $161 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Lilly USA, LLC | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Eisai Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| GE HEALTHCARE | 1 | $15 |
Products named: TAVNEOS, SAPHNELO, TALTZ, BENLYSTA, KRYSTEXXA, Leqembi, COSENTYX.
Industry payments across TX — which companies pay providers there.
